Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Digestive Diseases and Sciences - United States
doi 10.1007/s10620-018-4952-4
Full Text
Open PDFAbstract
Available in full text
Date
February 8, 2018
Authors
Publisher
Springer Science and Business Media LLC